- In this section:
- Contact our Virax specialists
Virax Biolabs is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs are focussed on developing T-Cell-based test technologies with the intention of providing an immunology profiling platform. T-Cell testing can be particularly effective in the diagnosis and therapeutics of post-viral syndromes.
Virax Biolabs’ ImmuneSelect portfolio includes peptide pools covering epitopes from pathogens, optimised for the stimulation of T cells. This includes offerings such as pools for SARS-CoV-2, SARS-CoV-2 MHC-1 ("CD8"), Lyme Disease, Cytomegalovirus ("CMV"), Respiratory Syncytial Virus ("RSV") and Epstein-Barr Virus ("EBV"), which continue to be regularly expanded.
ImmuneSelect's Recombinant Antibodies target cytokines and biomarkers, and they are available in different versions unconjugated to be tested on a range of applications including Flow Cytometry, ELISA and ELISpot/Fluorospot. ImmuneSelect is affordable, easy to use, and is compatible with most standard laboratory equipment.
Contact our Virax specialists today to learn more about the portfolio.
